FDA, COVID and local vaccine
Digest more
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.
Explore more